Treatment Response Biomarkers: Working Toward Personalized Radiotherapy for Lung Cancer.
J Thorac Oncol
; 19(8): 1164-1185, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-38615939
ABSTRACT
Owing to major advances in the field of radiation oncology, patients with lung cancer can now receive technically individualized radiotherapy treatments. Nevertheless, in the era of precision oncology, radiotherapy-based treatment selection needs to be improved as many patients do not benefit or are not offered optimum therapies. Cost-effective robust biomarkers can address this knowledge gap and lead to individuals being offered more bespoke treatments leading to improved outcome. This narrative review discusses some of the current achievements and challenges in the realization of personalized radiotherapy delivery in patients with lung cancer.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Precision Medicine
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
J Thorac Oncol
/
J. thorac. oncol
/
Journal of thoracic oncology
Year:
2024
Document type:
Article
Country of publication: